UROGEN PHARMA LTD.

(URGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart UROGEN PHARMA LTD.
Upcoming events on UROGEN PHARMA LTD.
06/08/22 Annual General Meeting
06/09/22 | 01:00pm Jefferies Healthcare Conference
08/15/22 Interim 2022 Earnings Release (Projected)
11/14/22 Q3 2022 Earnings Release (Projected)
03/16/23 FY 2022 Earnings Release (Projected)
05/11/23 Q1 2023 Earnings Release (Projected)
Past events on UROGEN PHARMA LTD.
05/25/22 | 11:00am H.C. Wainwright Global Life Sciences Investment Conference
05/16/22 | 02:50pm American urological association meeting - abstract number : pd58-06
05/16/22 | 09:45am American urological association meeting - abstract number : mp54-06-08
05/15/22 | 01:00pm American Urological Association Meeting
05/14/22 | 03:10pm American urological association meeting - abstract number : pd26-08
05/10/22 | 10:00am Q1 2022 Earnings Call
05/10/22 | 09:00am Q1 2022 Earnings Release
03/21/22 | 09:00am FY 2021 Earnings Call
03/21/22 | 07:00am FY 2021 Earnings Release
03/08/22 | 10:30am Cowen & Co. Health Care Conference
Past dividends on UROGEN PHARMA LTD.

- No events available -

Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread
8,16
7,82
4,3%
1,13
1,16
-2,4%
0,02
0,01
50%
11,8
11,5
2,7%
48,0
48,1
-0,13%
 
76,8
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread


 
-76,8

 
-109
-109
-0,58%
-126
-130
3,2%
-91,5
-90,2
-1,3%
 
-81,5
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-20,0
-18,1
-10,0%
-77,2
-72,6
-6,2%
-109
-106
-3,2%
-127
-131
3,1%
-92,3
-96,6
4,5%
 
-84,7
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-20,0
-17,6
-13%
-75,5
-71,0
-6,4%
-105
-101
-4,6%
-125
-127
1,5%
-109
-109
-0,01%
 
-115
 
Net income
M $
Released
Forecast
Spread
-20,0
-17,6
-13%
-75,7
-71,1
-6,4%
-105
-101
-3,6%
-128
-129
0,17%
-111
-109
-1,8%
 
-114
 
EPS
$
Released
Forecast
Spread
-2,14
-1,86
-15%
-4,80
-4,47
-7,3%
-5,12
-4,94
-3,7%
-5,90
-5,92
0,29%
-4,96
-4,84
-2,6%
 
-4,82
 
Announcement Date03/15/201802/28/201903/02/202003/18/202103/21/2022-
Quarterly results
Fiscal Period : December2021 Q12021 Q22021 Q32021 Q42022 Q12022 Q2
Sales
M $
Released
Forecast
Spread
7,49
9,05
-17%
13,0
11,8
11%
11,4
15,4
-26%
16,2
16,5
-1,9%
13,6
15,2
-11%
 
17,4
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread


 


 


 


 


 
 

 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-26,1
-29,1
10%
-22,8
-25,8
12%
-23,4
-26,9
13%
-19,9
-22,3
11%
-22,0
-24,0
8,5%
 
-22,4
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-25,9
-29,7
13%
-25,9
-26,4
1,9%
-30,2
-28,7
-5,4%
-27,3
-28,2
3,2%
-28,1
-31,3
10%
 
-30,0
 
Net income
M $
Released
Forecast
Spread
-25,9
-28,1
7,8%
-26,2
-26,3
0,16%
-30,2
-30,1
-0,41%
-28,5
-27,3
-4,4%
-28,4
-30,3
6,4%
 
-29,6
 
EPS
$
Released
Forecast
Spread
-1,17
-1,27
7,6%
-1,17
-1,14
-2,5%
-1,35
-1,29
-4,5%
-1,27
-1,20
-6,2%
-1,25
-1,34
6,9%
 
-1,30
 
Announcement Date05/13/202108/04/202111/15/202103/21/202205/10/2022-
Previous year Next Year
Upcoming sector events for UROGEN PHARMA LTD.
More events
Past sector events for UROGEN PHARMA LTD.
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise